Formulation Development
Nouscom’s Off-the-Shelf Neoantigen Immunotherapy Continues to Elicit Potent & Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to "Intercept" Cancer
Nouscom recently announced further promising data from the fully enrolled Phase 1b/2 study evaluating NOUS-209 for its potential to "intercept" cancer in Lynch Syndrome (LS)…
MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases
MannKind Corporation recently announced the successful completion of its first-in-human Phase 1 study of nintedanib DPI (MNKD-201) for pulmonary fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).…
EMA Confirms Acceptance of Marketing Authorization Application for a Proposed Biosimilar to Simponi
Alvotech and Advanz Pharma recently announced the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT05, Alvotech’s proposed biosimilar to Simponi (golimumab),…
Can-Fite Anti-Obesity Drug Received Patent Allowance in Australia
Can-Fite BioPharma Ltd. recently announced an update related to the intellectual property (IP) status of its lead drug candidate Namodenoson, currently being developed for the…
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
Conduit Pharmaceuticals Inc. recently announced the filing of two new patent applications relating to its lead clinical candidate, AZD1656, a HK-4 glucokinase activator licensed from…
SGS Announces Expansion of Biopharmaceutical Testing Capabilities
SGS recently announced it has added new capacity and capabilities at its center of excellence in Lincolnshire, IL. This expansion adds new instrumentation and expertise…
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease & Neuroscience Pipeline
AbbVie and Aliada Therapeutics recently announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology company advancing therapies using a novel blood-brain barrier…
Quotient Sciences & Medicines for Malaria Venture Announce Dosing of First-Ever Long-Acting Injectable for Malaria Prevention to Study Volunteers
Medicines for Malaria Venture (MMV) and Quotient Sciences have begun the first clinical trial for a long-acting injectable (LAI) preventive compound for malaria. The trial, conducted in healthy…
Intensity Therapeutics & The Swiss Group for Clinical Cancer Research SAKK Announce First Patient Dosed in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK are collaborating in the INVINCIBLE-4 Study, a Phase 2 trial to treat patients…
Curevo Presents Positive Shingles Vaccine Outcomes Data
Curevo Vaccine recently announced an upcoming oral presentation at the World Vaccine Congress in Barcelona of shingles case outcomes data from an 876-patient Phase 2…
Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis
Karyopharm Therapeutics Inc. recently announced that, following feedback from the US FDA, it will be replacing TSS50, one of the co-primary endpoints in the Phase…
Evogene Announces Collaboration With Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
Evogene Ltd. recently announced a collaboration with Google Cloud to develop a cutting-edge foundation model for generative small molecule de novo design, propelling Evogene’s ChemPass…
Palisade Bio Announces Positive Data from Two Ex Vivo Translational Studies for Ulcerative Colitis Treatment
Palisade Bio, Inc. recently announced the presentation of data from two translational studies demonstrating the ex vivo bioactivation of PALI-2108 in stool samples and whole blood.…
Sterling Pharma Solutions Expands GMP ADC Manufacturing Capacity at Deeside, UK
Sterling Pharma Solutions recently announced the second phase of an expansion strategy at its Deeside, UK, site to support antibody-drug conjugate (ADC) development, with a…
Abzena Announces Major Expansion in Microbiology Laboratory Space in Support of Biologic Manufacturing
Abzena recently announced a significant expansion in their quality control (QC) testing capabilities at their San Diego, CA, biologics development and cGMP manufacturing site. The…
PCI Pharma Services Wins Supply Chain Excellence Award for Groundbreaking Digital Platform to Manage Clinical Trials & Commercial Lifespans
PCI Pharma Services has earned a Supply Chain Excellence Award USA for a first-of-its-kind digital solution for clinical trials and commercial lifespan management. The company’s pci…
Novartis Scemblix FDA Approved in Newly Diagnosed CML, Offering Superior Efficacy & Favorable Safety & Tolerability Profile
Novartis recently announced Scemblix (asciminib) was granted accelerated approval by the US FDA for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in…
Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients With Solid Tumors
Numab Therapeutics AG recently announced the start of a Phase 1 clinical trial evaluating NM32, a next-generation tri-specific immuno-oncology therapeutic targeting the receptor tyrosine kinase-like…
Enlivex Receives Notice of Allowance for Patent Application Covering the Use of Allocetra in Patients With Osteoarthritis
Enlivex Therapeutics Ltd. recently announced the Japanese Patent Office issued a notice of allowance for patent application number 2022-512861 titled Therapeutic Apoptotic Cells for Treatment…
Tiziana Life Sciences Announces Positive Results From Ozempic & Nasal Anti-CD3 Combination Study
Tiziana Life Sciences, Ltd. recently announced positive results demonstrating the anti-inflammatory potential of its anti-CD3 antibody (foralumab) in combination with semaglutide, a GLP-1 agonist marketed…
